Your browser doesn't support javascript.
loading
Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease.
Xu, Yunwen; Chang, Alexander R; Inker, Lesley A; McAdams-DeMarco, Mara; Grams, Morgan E; Shin, Jung-Im.
Affiliation
  • Xu Y; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (Y.X., M.E.G., J.-I.S.).
  • Chang AR; Department of Nephrology, Geisinger Health System, Danville, PA (A.R.C.).
  • Inker LA; Division of Nephrology, Department of Internal Medicine, Tufts Medical Center, Boston, MA (L.A.I.).
  • McAdams-DeMarco M; Department of Surgery (M.M.-D.), New York University Grossman School of Medicine and Langone Health.
  • Grams ME; Department of Population Health (M.M.-D., M.E.G.), New York University Grossman School of Medicine and Langone Health.
  • Shin JI; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (Y.X., M.E.G., J.-I.S.).
Circulation ; 148(19): 1445-1454, 2023 11 07.
Article in En | MEDLINE | ID: mdl-37681341
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Stroke / Embolism / Renal Insufficiency, Chronic Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Circulation Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Stroke / Embolism / Renal Insufficiency, Chronic Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Circulation Year: 2023 Type: Article